Invention Grant
- Patent Title: Method for treating cancer
-
Application No.: US15851978Application Date: 2017-12-22
-
Publication No.: US10369155B2Publication Date: 2019-08-06
- Inventor: Heike Keilhack
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Christine Pemberton
- Main IPC: A61K31/45
- IPC: A61K31/45 ; A61K45/06 ; A61P35/00 ; A61P37/00 ; A61K31/453 ; A61K31/5375 ; A61K31/5377

Abstract:
The present invention provides a method for treating or alleviating a symptom of a disorder, e.g., immune evasion, cancer-cell induced immune dysfunction, reduced immune response, lowered inflammation, decreased expression of a major histocompatibility complex (MHC), or cancer, characterized by aberrant, misregulated, or increased Enhancer of Zeste Homolog 2 (EZH2) activity in a cell or subject in need thereof by contacting the cell or administering to the subject a therapeutically effective amount of an EZH2 inhibitor.
Public/Granted literature
- US20180133224A1 METHOD FOR TREATING CANCER Public/Granted day:2018-05-17
Information query
IPC分类: